Correction: NCAPD2 is a favorable predictor of prognostic and immunotherapeutic biomarker for multiple cancer types including lung cancer.

Feng, Linyuan; Yang, Yang; Lin, Zhenhua; Cui, Minghua; Jin, Aihua; Cui, Aili

Feng, Linyuan; Yang, Yang; Lin, Zhenhua; Cui, Minghua; Jin, Aihua; Cui, Aili.

Afiliación

Feng L; Yanbian University Hospital, Yanji, China.
Yang Y; Key Laboratory of Pathobiology of High Frequency Oncology in Ethnic Minority Areas, Yanbian University, State Ethnic Affairs Commission, Yanji, China.
Lin Z; Key Laboratory of Pathobiology of High Frequency Oncology in Ethnic Minority Areas, Yanbian University, State Ethnic Affairs Commission, Yanji, China.
Cui M; Yanbian University Hospital, Yanji, China.
Jin A; Key Laboratory of Pathobiology of High Frequency Oncology in Ethnic Minority Areas, Yanbian University, State Ethnic Affairs Commission, Yanji, China.
Cui A; Key Laboratory of Pathobiology of High Frequency Oncology in Ethnic Minority Areas, Yanbian University, State Ethnic Affairs Commission, Yanji, China.

Genes Environ ; 46(1): 6, 2024 Feb 13.

Article en En | MEDLINE | ID: mdl-38347640

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Genes Environ Año: 2024 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google